P.O. Box 2009
9640 CA Veendam
t: +31 598 62 37 31
Cannabis dosing is not that easy. Like with other medicines, individual patients will respond differently to medicinal cannabis. Read about it:
1.9 million euros for research into neuropathic pain. Read the interview with neurologist Geert Jan Groeneveld who will conduct the research, together with professor Dahan.
2 weeks ago
Cannabis dosing is not that easy. Like with other medicines, individual patients will respond differently to medicinal cannabis. Their response depends on the cannabis product used and the condition being treated. The duration of treatment, administration and genetic predispositions are important factors too. Read about it:https://bedrocan.com/cannabis-inside/cannabis-dosing/ … See MoreSee Less
Cannabis dosing is not easy. It varies from patient to patient.
Cannabis dosing is not easy. Dosage varies from patient to patient and should be built up slowly, wh…
Share on FacebookShare on TwitterShare on Linked InShare by Email
3 weeks ago
The Dutch government is supporting research into the use of medicinal cannabis in the treatment of neuropathic pain with € 1.9 million. Bedrocan’s raw materials will be used for the production of the research material. Neurologist Geert Jan Groeneveld (CSO / CMO at CHDR and professor of Clinical Neuropharmacology at the LUMC) and Albert Dahan (professor of Anesthesiology at the LUMC) will conduct the research.https://bedrocan.com/1-9-million-euros-for-research-into-neuropathic-pain/ … See MoreSee Less
Neuropathic pain and research on the best THC – CBD ratio
1.9 million euros for research into neuropathic pain and the ideal ratio between THC and CBD to comb…
We're not around right now. But you can send us an email and we'll get back to you, asap.
Start typing and press Enter to search